FOXM1 and neoplasm: The combined analysis of 23 studies showed that FOXM1 overexpression in tumor tissue was associated with worse 3-year OS (OR = 3.30, 95% CI = 2.56 to 4.25, P < 0.00001), 5-year OS (OR = 3.35, 95% CI = 2.64 to 4.26, P < 0.00001) and 10-year OS (OR = 5.24, 95% CI = 2.61 to 10.52, P < 0.00001) of solid tumors (Figure 2).